( NASDAQ-NMS:BSTC )

News from BioSpecifics Technologies Corp. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 10, 2017, 08:00 ET BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Nov 07, 2017, 08:01 ET BioSpecifics Technologies Corp. to Present at the Stifel 2017 Healthcare Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Sep 20, 2017, 08:00 ET BioSpecifics Technologies Corp. to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Sep 05, 2017, 08:00 ET BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Aug 09, 2017, 16:01 ET BioSpecifics Technologies Corp. Reports Second Quarter 2017 Financial Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Jun 02, 2017, 16:05 ET BioSpecifics Technologies Corp. to Present at the Jefferies 2017 Healthcare Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


May 10, 2017, 16:05 ET BioSpecifics Technologies Corp. Reports First Quarter 2017 Financial Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Apr 18, 2017, 08:00 ET BioSpecifics Technologies Corp. Initiates Phase 1 Clinical Trial of XIAFLEX for Treatment of Uterine Fibroids

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Mar 29, 2017, 16:30 ET BioSpecifics Technologies Corp. to Present at the 16th Annual Needham Healthcare Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Mar 15, 2017, 08:00 ET BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2016 Financial Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Jan 24, 2017, 16:30 ET BioSpecifics Technologies Corp. to Present at NobleCon13 - Noble Capital Markets' Thirteenth Annual Investor Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Nov 17, 2016, 16:05 ET BioSpecifics Technologies Corp. Announces Positive Data from Phase 2b Study of CCH in Patients with Cellulite

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Nov 09, 2016, 16:05 ET BioSpecifics Technologies Corp. Reports Third Quarter 2016 Financial Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Nov 08, 2016, 08:00 ET BioSpecifics Technologies Corp. to Present at Stifel 2016 Healthcare Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Nov 02, 2016, 08:00 ET BioSpecifics Technologies Corp. to Report Third Quarter 2016 Financial Results on Wednesday, November 9, 2016

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Sep 02, 2016, 08:00 ET BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Aug 09, 2016, 16:05 ET BioSpecifics Technologies Corp. Reports Second Quarter 2016 Financial Results

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Aug 02, 2016, 08:00 ET BioSpecifics Technologies Corp. to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Jun 13, 2016, 07:30 ET BioSpecifics Technologies Corp. Announces Positive Top-Line Results from Phase 2 Trial of CCH for Treatment of Human Lipoma

 BioSpecifics Technologies Corp. (NASDAQ: BSTC) today announced positive, statistically significant top-line results from a placebo-controlled,...


Jun 02, 2016, 07:30 ET BioSpecifics Technologies Corp. to Present at the Jefferies 2016 Healthcare Conference

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


May 31, 2016, 07:30 ET BioSpecifics Technologies Corp. Announces Publication of Encouraging Data for Uterine Fibroid Treatment with CCH in American Journal of Obstetrics & Gynecology

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


May 10, 2016, 07:30 ET BioSpecifics Technologies Corp. Reports First Quarter 2016 Financial Results

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


May 03, 2016, 08:00 ET BioSpecifics Technologies Corp. to Report First Quarter 2016 Financial Results on Tuesday, May 10, 2016

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Mar 14, 2016, 07:00 ET BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2015 Financial Results

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Mar 08, 2016, 08:00 ET BioSpecifics Technologies Corp. to Present at the 28th Annual ROTH Conference

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...